Session » ARHP Noteworthy Abstracts

Meeting: 2013 ACR/ARHP Annual Meeting

Abstract Number: 832

Factors That Affect Tender and Swollen Joint Counts In Rheumatoid Arthritis

Abstract Number: 833

Cardiovascular Diseases In Rheumatoid Arthritis: Can Early Treatment With Disease-Modifying Antirheumatic Drugs Alter The Risk?

Abstract Number: 834

Physical Activity Behavior In Patients With Arthritis

Abstract Number: 835

The Association Of Worsening Structural Disease With Trajectories Of Decline In Physical Function In Knee Osteoarthritis: Results From Two Cohort Studies

Abstract Number: 836

Comprehensive Behavioral Intervention Compared To Standard Of Care Exercise Program After Total Knee Arthroplasty: A Pilot Randomized Trial

Abstract Number: 837

The Validity Of The Satisfaction With Appearance Scale and The Brief Satisfaction With Appearance Scale For Patients With Limited and Diffuse Systemic Sclerosis

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under embargo once the ACR has notified presenters of their abstract’s acceptance, and cannot be presented at other meetings after this time. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until November 7 at 10:00 AM ET. Journalists with access to embargoed information also cannot release articles before this time.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Permissions and Reprints

For information about abstract permissions and reprints, see ACR Convergence permissions and reprint policies.